Annexon Biosciences Sets Terms for its Initial Public Offering

Annexon Biosciences set terms for its initial public offering on Monday, with plans to offer 10 million shares priced at $14 to $16 each…

The company has applied to list on Nasdaq, under the ticker “ANNX.”

JP Morgan, BofA Securities and Cowen are underwriting the deal.

Proceeds will be used to fund clinical trials, R&DS and for working capital and other general corporate purposes.

“We are a clinical-stage biopharmaceutical company developing a pipeline of…

Continue reading at MARKETWATCH.com

 

 

You May Also Like

About the Author: Admin